Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

Bowel cancer rates have been rising in people under 55 for years. But scientists have yet to determine the reason.

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

Following on from their breakthrough human trial that successfully reprogrammed the immune system to overpower glioblastoma, an aggressive brain tumor, the same scientists have now further developed ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Ovarian cancer often goes undetected for a long time. In seven out of 10 patients, the tumor has already formed secondary ...

Two major eastern Idaho hospitals are taking a groundbreaking step to improve cancer care through a new technology that ...